LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Portola Pharmaceuticals

Similar companies to Portola Pharmaceuticals

Portola Pharmaceuticals Tech Stack

Portola Pharmaceuticals uses 8 technology products and services including Matomo, Practice Fusion, jQuery UI, and more. Explore Portola Pharmaceuticals's tech stack below.

  • Matomo
    Analytics
  • Practice Fusion
    Electronic Health Records
  • jQuery UI
    Javascript Libraries
  • Splunk
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Python
    Programming Languages
  • Adobe Creative Suite
    Visualisation Software
  • Facebook
    Widgets

Media & News

Portola Pharmaceuticals's Email Address Formats

Portola Pharmaceuticals uses at least 1 format(s):
Portola Pharmaceuticals Email FormatsExamplePercentage
FLast@portola.comJDoe@portola.com
47%
First.Last@portola.comJohn.Doe@portola.com
6%
FLast@portola.comJDoe@portola.com
47%

Frequently Asked Questions

Where is Portola Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Portola Pharmaceuticals's main headquarters is located at 270 East Grand Ave. South San Francisco, CA 94080 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Portola Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Portola Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Portola Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Portola Pharmaceuticals is a publicly traded company; the company's stock symbol is PTLA.

What is Portola Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Portola Pharmaceuticals's official website is portola.com and has social profiles on LinkedIn.

How much revenue does Portola Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of March 2024, Portola Pharmaceuticals's annual revenue reached $75M.

What is Portola Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Portola Pharmaceuticals's SIC code is 3544 - Special Dies and Tools, Die Sets, Jigs and Fixtures, and Industrial Molds NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Portola Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of March 2024, Portola Pharmaceuticals has approximately 201 employees across 4 continents, including North AmericaEuropeAsia. Key team members include CEO: V. G.Vice President Sales: R. S. L.Head Data Management & Biostatistics: B. A.. Explore Portola Pharmaceuticals's employee directory with LeadIQ.

What industry does Portola Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Portola Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Portola Pharmaceuticals use?

Minus sign iconPlus sign icon
Portola Pharmaceuticals's tech stack includes MatomoPractice FusionjQuery UISplunkWP EnginePythonAdobe Creative SuiteFacebook.

What is Portola Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Portola Pharmaceuticals's email format typically follows the pattern of . Find more Portola Pharmaceuticals email formats with LeadIQ.

How much funding has Portola Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of March 2024, Portola Pharmaceuticals has raised $259M in funding. The last funding round occurred on Aug 13, 2019 for $259M.

When was Portola Pharmaceuticals founded?

Minus sign iconPlus sign icon
Portola Pharmaceuticals was founded in 2003.
Portola Pharmaceuticals

Portola Pharmaceuticals

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions.
 
The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers.
 
We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines.

Section iconCompany Overview

Headquarters
270 East Grand Ave. South San Francisco, CA 94080 US
Phone number
SIC Code
3544 - Special Dies and Tools, Die Sets, Jigs and Fixtures, and Industrial Molds
Stock Symbol
PTLA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $259M

    Portola Pharmaceuticals has raised a total of $259M of funding over 11 rounds. Their latest funding round was raised on Aug 13, 2019 in the amount of $259M.

  • $50M$100M

    Portola Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $259M

    Portola Pharmaceuticals has raised a total of $259M of funding over 11 rounds. Their latest funding round was raised on Aug 13, 2019 in the amount of $259M.

  • $50M$100M

    Portola Pharmaceuticals's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.